MVS client unites forces to fight malaria

A recent article appearing in the Wall Street Journal highlighted the progressive, life-saving attempts being put forth by Medicines for Malaria Venture, a patent client with McKee, Voorhees, & Sease, PLC. MVS has assisted MMV in patenting \'SPIRO and DISPIRO 1,2,4-Trioxolane Antimalarials\' U.S. Patent No. 6,486,199.MMV is a Geneva, Switzerland-based research group trying to pick up the pieces from past failed attempts to bring a better drug to fight malaria to the market in a timely fashion. To read more, log on to www.wsj.com and in the search field, type


Return to MVS News

Connect with MVS

Enter your name and email address to recieve the latest news and updates from us and our attorneys.

Subscribe to: MVS Newsletter

Subscribe to: Filewrapper® Blog Updates

  I have read and agree to the terms and conditions of McKee, Voorhees & Sease, P.L.C.